Your browser doesn't support javascript.
loading
Sex-differential effects of olanzapine vs. aripiprazole on glucose and lipid metabolism in first-episode schizophrenia
ZHOU, XUE-MEI; HU, MAO-RONG; GONG, MEI-YU; ZOU, XUE-LIANG; YU, ZHI-MIN.
  • ZHOU, XUE-MEI; Jiangxi Mental Health Centre. Nanchang. CN
  • HU, MAO-RONG; Nanchang University. The First Affiliated Hospital. Nanchang. CN
  • GONG, MEI-YU; Jiangxi Mental Health Centre. Nanchang. CN
  • ZOU, XUE-LIANG; Jiangxi Mental Health Centre. Nanchang. CN
  • YU, ZHI-MIN; Jiangxi Mental Health Centre. Nanchang. CN
Arch. Clin. Psychiatry (Impr.) ; 46(2): 33-39, Mar.-Apr. 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1011143
ABSTRACT
Abstract Objective To compare sex difference in metabolic effect of olanzapine versus aripiprazole on schizophrenia. Methods A twelve-week prospective open-label cohort study to compare four subgroups according to first-episode schizophrenia patients' type of drug usage and sex female aripiprazole (n = 11), male aripiprazole (n = 11), female olanzapine (n = 10), and male olanzapine (n = 11) for body mass index, fasting serum triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and fasting glucose. Results Aripiprazole may be associated with weight gain in female patients with low-baseline weight. Aripiprazole may have an adverse effect of weight and favorable effects of circulating glucose and lipid on female over male schizophrenia patients. The aripiprazole-induced changes in glucose and lipid may be independent of body fat storage, especially for female schizophrenia patients. Olanzapine may have adverse effects of weight, glucose and lipid profiles on female over male schizophrenic patients. Discussion Our findings fill the gap in knowledge and provide a sex-specific guidance to psychiatrist better tailoring treatment to individual sex-differential characteristics and a key clue to understand the sex-differential mechanism of antipsychotics-induced metabolic dysfunction.
Assuntos


Texto completo: DisponíveL Índice: LILACS (Américas) Assunto principal: Glicemia / Metabolismo dos Lipídeos / Aripiprazol / Olanzapina Tipo de estudo: Guia de Prática Clínica / Estudo observacional / Estudo prognóstico / Fatores de risco Limite: Adulto / Feminino / Humanos / Masculino Idioma: Inglês Revista: Arch. Clin. Psychiatry (Impr.) Assunto da revista: Psiquiatria Ano de publicação: 2019 Tipo de documento: Artigo País de afiliação: China Instituição/País de afiliação: Jiangxi Mental Health Centre/CN / Nanchang University/CN

Similares

MEDLINE

...
LILACS

LIS


Texto completo: DisponíveL Índice: LILACS (Américas) Assunto principal: Glicemia / Metabolismo dos Lipídeos / Aripiprazol / Olanzapina Tipo de estudo: Guia de Prática Clínica / Estudo observacional / Estudo prognóstico / Fatores de risco Limite: Adulto / Feminino / Humanos / Masculino Idioma: Inglês Revista: Arch. Clin. Psychiatry (Impr.) Assunto da revista: Psiquiatria Ano de publicação: 2019 Tipo de documento: Artigo País de afiliação: China Instituição/País de afiliação: Jiangxi Mental Health Centre/CN / Nanchang University/CN